TYCB yields 2.59% · JNJ yields 2.14%● Live data
📍 TYCB pulled ahead of the other in Year 1
Combined, TYCB + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TYCB + JNJ for your $10,000?
Calvin B. Taylor Bankshares, Inc. operates as the holding company for Calvin B. Taylor Banking Company that provides commercial banking products and services. It accepts checking, money market, savings, and individual retirement accounts, as well as certificates of deposit. The company also offers consumer loans to individuals for personal, family, or household purchases, such as automobiles, trucks and vans, mobile homes, and personal expenses; mortgage loans comprising secured loans to individuals to purchase, construct, or enhance a primary or second home property; commercial loans, including secured and unsecured loans for business and professional purposes to retailers, wholesalers, service and related businesses, and manufacturers. In addition, it provides debit cards; ATM services; and online, mobile, and phone banking services. The company has 12 banking locations within the eastern coastal area of the Delmarva Peninsula, including Worcester County, Maryland; Sussex County, Delaware; and Accomack County, Virginia. Calvin B. Taylor Bankshares, Inc. was founded in 1890 and is headquartered in Berlin, Maryland.
Full TYCB Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.